nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—hair follicle—melanoma	0.126	0.422	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—MYO7A—melanoma	0.102	0.146	CbGpPWpGaD
Nitroxoline—METAP2—retina—melanoma	0.0623	0.208	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—AKR1B10—melanoma	0.0602	0.0858	CbGpPWpGaD
Nitroxoline—METAP2—mammalian vulva—melanoma	0.0499	0.167	CbGeAlD
Nitroxoline—METAP2—Inactivation, recovery and regulation of the phototransduction cascade—PRKCA—melanoma	0.0474	0.0676	CbGpPWpGaD
Nitroxoline—METAP2—The phototransduction cascade—PRKCA—melanoma	0.0462	0.066	CbGpPWpGaD
Nitroxoline—METAP2—head—melanoma	0.0357	0.119	CbGeAlD
Nitroxoline—METAP2—lymph node—melanoma	0.025	0.0836	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—PRKCA—melanoma	0.0198	0.0283	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYO7A—melanoma	0.013	0.0185	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HS3ST5—melanoma	0.011	0.0157	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DRAP1—melanoma	0.00908	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYO7A—melanoma	0.00908	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TRRAP—melanoma	0.00786	0.0112	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CUL3—melanoma	0.00786	0.0112	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TAS2R60—melanoma	0.00772	0.011	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKR1B10—melanoma	0.00764	0.0109	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LUM—melanoma	0.00681	0.00971	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HPSE—melanoma	0.00668	0.00953	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CUBN—melanoma	0.00656	0.00935	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CSPG4—melanoma	0.00633	0.00903	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS3—melanoma	0.00623	0.00888	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SKI—melanoma	0.00613	0.00875	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLCB4—melanoma	0.00585	0.00834	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL1—melanoma	0.00585	0.00834	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CUL3—melanoma	0.0055	0.00785	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TRRAP—melanoma	0.0055	0.00785	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKR1B10—melanoma	0.00535	0.00763	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC6—melanoma	0.00506	0.00722	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—F2RL1—melanoma	0.00498	0.0071	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NPPA—melanoma	0.0048	0.00684	CbGpPWpGaD
Nitroxoline—METAP2—Disease—VCAN—melanoma	0.00468	0.00668	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM3—melanoma	0.00468	0.00667	CbGpPWpGaD
Nitroxoline—METAP2—Disease—WNT5A—melanoma	0.00465	0.00663	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KISS1—melanoma	0.00443	0.00632	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SKI—melanoma	0.00429	0.00612	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR1—melanoma	0.00429	0.00612	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MC1R—melanoma	0.00423	0.00603	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRM1—melanoma	0.00406	0.00578	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCR7—melanoma	0.00406	0.00578	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SUFU—melanoma	0.00395	0.00564	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GAB2—melanoma	0.00373	0.00532	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RHOB—melanoma	0.00369	0.00526	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BCL2L11—melanoma	0.00369	0.00526	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FASN—melanoma	0.00365	0.00521	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC6—melanoma	0.00354	0.00506	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CXCR4—melanoma	0.00351	0.005	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HDAC2—melanoma	0.00351	0.005	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FOXO4—melanoma	0.00351	0.005	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD44—melanoma	0.00347	0.00495	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR2—melanoma	0.00336	0.00479	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RAC2—melanoma	0.00331	0.00472	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFC—melanoma	0.00325	0.00464	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WNT5A—melanoma	0.00325	0.00464	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT3—melanoma	0.0032	0.00457	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—F2R—melanoma	0.00286	0.00408	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB4—melanoma	0.00283	0.00403	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN2B—melanoma	0.0028	0.004	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EDNRB—melanoma	0.00277	0.00395	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD86—melanoma	0.00271	0.00387	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTK2B—melanoma	0.00269	0.00383	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF1—melanoma	0.00263	0.00375	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAB2—melanoma	0.00261	0.00373	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNA11—melanoma	0.00261	0.00373	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FLT1—melanoma	0.0026	0.00371	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFRA—melanoma	0.00255	0.00363	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRKCA—melanoma	0.00252	0.0036	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERCC2—melanoma	0.0025	0.00357	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAP2K2—melanoma	0.00246	0.00351	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FOXO4—melanoma	0.00246	0.0035	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HDAC2—melanoma	0.00246	0.0035	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR4—melanoma	0.00246	0.0035	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNAQ—melanoma	0.00243	0.00347	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TERT—melanoma	0.00234	0.00334	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HLA-A—melanoma	0.00234	0.00334	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RAC1—melanoma	0.00234	0.00333	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SYK—melanoma	0.00228	0.00326	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ITGAV—melanoma	0.00224	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NGFR—melanoma	0.00224	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT3—melanoma	0.00224	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HIF1A—melanoma	0.00224	0.0032	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SOCS1—melanoma	0.00208	0.00296	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—S100B—melanoma	0.00207	0.00295	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS2—melanoma	0.00204	0.00291	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOTCH1—melanoma	0.00202	0.00288	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB4—melanoma	0.00198	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD80—melanoma	0.00198	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KIT—melanoma	0.00197	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APC—melanoma	0.00197	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN2B—melanoma	0.00196	0.0028	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGF—melanoma	0.00195	0.00278	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CD86—melanoma	0.0019	0.00271	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EDN1—melanoma	0.00188	0.00269	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BRAF—melanoma	0.00186	0.00265	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CSF2—melanoma	0.00184	0.00263	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF1—melanoma	0.00184	0.00263	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—E2F1—melanoma	0.0018	0.00257	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFRA—melanoma	0.00178	0.00254	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ITGB3—melanoma	0.00177	0.00252	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRKCA—melanoma	0.00177	0.00252	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAP2K1—melanoma	0.00175	0.00249	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CD—melanoma	0.00174	0.00248	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SPP1—melanoma	0.00173	0.00247	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAP2K2—melanoma	0.00173	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF2—melanoma	0.00166	0.00237	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TERT—melanoma	0.00164	0.00234	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RAC1—melanoma	0.00164	0.00233	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HIF1A—melanoma	0.00157	0.00224	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MDM2—melanoma	0.00156	0.00222	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB2—melanoma	0.00153	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CB—melanoma	0.00151	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD4—melanoma	0.00151	0.00215	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KDR—melanoma	0.0015	0.00214	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—melanoma	0.0015	0.00214	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FN1—melanoma	0.00144	0.00206	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1B—melanoma	0.00142	0.00203	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH1—melanoma	0.00141	0.00202	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CD80—melanoma	0.00139	0.00198	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APC—melanoma	0.00138	0.00197	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KIT—melanoma	0.00138	0.00197	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CG—melanoma	0.00138	0.00197	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGF—melanoma	0.00137	0.00195	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CTNNB1—melanoma	0.00134	0.00191	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1A—melanoma	0.00131	0.00187	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTEN—melanoma	0.00131	0.00186	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BRAF—melanoma	0.0013	0.00185	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1—melanoma	0.00127	0.00181	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAP2K1—melanoma	0.00122	0.00175	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CD—melanoma	0.00122	0.00173	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—melanoma	0.00117	0.00167	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NRAS—melanoma	0.00117	0.00166	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF2—melanoma	0.00116	0.00166	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK3—melanoma	0.00112	0.00159	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MDM2—melanoma	0.00109	0.00155	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—melanoma	0.00109	0.00155	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB2—melanoma	0.00107	0.00153	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK1—melanoma	0.00106	0.00152	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGFR—melanoma	0.00106	0.00152	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CB—melanoma	0.00106	0.00151	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL8—melanoma	0.00102	0.00145	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KRAS—melanoma	0.001	0.00143	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1B—melanoma	0.000994	0.00142	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—melanoma	0.000975	0.00139	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL2—melanoma	0.000973	0.00139	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCND1—melanoma	0.000949	0.00135	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CTNNB1—melanoma	0.000939	0.00134	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—melanoma	0.000922	0.00132	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—melanoma	0.000921	0.00131	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1A—melanoma	0.000918	0.00131	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTEN—melanoma	0.000916	0.00131	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NFKB1—melanoma	0.000911	0.0013	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HRAS—melanoma	0.000853	0.00122	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—melanoma	0.000827	0.00118	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—melanoma	0.000819	0.00117	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRAS—melanoma	0.000817	0.00116	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—melanoma	0.000817	0.00116	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK3—melanoma	0.000782	0.00112	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—melanoma	0.000761	0.00109	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—melanoma	0.000753	0.00107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK1—melanoma	0.000744	0.00106	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGFR—melanoma	0.000744	0.00106	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KRAS—melanoma	0.000703	0.001	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—melanoma	0.000646	0.000921	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—melanoma	0.000625	0.000891	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRAS—melanoma	0.000598	0.000852	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—melanoma	0.000572	0.000816	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—melanoma	0.000528	0.000753	CbGpPWpGaD
